Research and Innovation

LIke ThisLIke ThisLIke ThisLIke ThisLIke This

Contact the Interstitial Lung Disease Program

  • 617-355-1900
  • International: +1-617-355-5209
The Interstitial Lung Disease program at Boston Children's is a part of the Children’s Interstitial Lung Disease Research Network (chILDRN), a network of physician-scientists from across the country who work together to conduct research to advance the field of these rare disorders. As core members of this working group, our physicians have been integral in the formation of a new multicenter ILD database, that can be used to further improve our understanding and treatment of children with these diseases, and publication of a consensus Clinical Practice Guidelines for infants with ILD.

Our researchers contributed to a recently published pivotal genotype-phenotype correlation study in ABCA3 surfactant protein deficiency. Additionally, there are active collaborative research projects at Boston Children’s between the Pulmonary Division and the Manton Center, enrolling families for whole exome sequencing to identify genetic causes for rare diffuse lung disorders. Several promising genes have already been identified.
We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital 300 Longwood Avenue, Boston, MA 02115 617-355-6000 | 800-355-7944

Close